Evidence map›Paper›PMID 39572731›Full record

ReviewNature protocols2025

Biolayer interferometry for measuring the kinetics of protein-protein interactions and nanobody binding.

Timothy A Bates, Sintayehu K Gurmessa, Jules B Weinstein, Mila Trank-Greene, Xammy Huu Wrynla, Aidan Anastas, Teketay Wassie Anley, Audrey Hinchliff, Ujwal Shinde, John E Burke and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. High-Throughput BLI for One-Step Anti-International journal of molecular sciences · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Mapping SARS-CoV-2 Nucleocapsid Function with Nanobodies.bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Timothy A BatesDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, USA. batesti@ohsu.edu.
Sintayehu K GurmessaDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, USA.
Jules B WeinsteinDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, USA.
Mila Trank-GreeneDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, USA.
Xammy Huu WrynlaDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, USA.
Aidan AnastasDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, USA.
Teketay Wassie AnleyDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, USA.
Audrey HinchliffDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, USA.
Ujwal ShindeDepartment of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, OR, USA.
John E BurkeDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.ORCID 0000-0001-7904-9859
Fikadu G TafesseDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, USA. tafesse@ohsu.edu.ORCID 0000-0002-8575-4164

Funding

Multidisciplinary Research Training in Pulmonary MedicineT32HL083808 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEWINSOHN, DAVID M., SLATORE, CHRISTOPHER G. · 2008 to 2025
$5.3M
Determining the role of sphingolipids in Mycobacterium tuberculosis infectionR01AI141549 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI TAFESSE, FIKADU G. · 2020 to 2025
$2.4M
Defining the role of host lipid repertoire in Mycobacterium tuberculosis infectionR21AI124225 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI TAFESSE, FIKADU G. · 2017 to 2018
$424k
Determining the role of host lipids in Zika virus infectionR21AI133631 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI TAFESSE, FIKADU G. · 2017 to 2018
$424k
Octet Red384S10OD023413 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI BARR-GILLESPIE, PETER GORDON · 2017 to 2017
$318k
Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) 168998Michael Smith Foundation for Health Research (MSFHR) 17686NIAID NIH HHS R01 AI141549NIAID NIH HHS R21 AI124225NIAID NIH HHS R21 AI133631NIH HHS S10 OD023413U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01AI141549U.S. Department of Health & Human Services | National Institutes of Health (NIH) S10OD023413U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) 5T32HL083808
6 · The paper itself

Abstract

Protein-protein interactions underpin nearly all biological processes, and understanding the molecular mechanisms that govern these interactions is crucial for the progress of biomedical sciences. The emergence of artificial intelligence-driven computational tools can help reshape the methods of structural biology; however, model data often require empirical validation. The large scale of predictive modeling data will therefore benefit from optimized methodologies for the high-throughput biochemical characterization of protein-protein interactions. Biolayer interferometry is one of very few approaches that can determine the rate of biomolecular interactions, called kinetics, and, of the commonly available kinetic measurement techniques, it is the most suitable for high-throughput experimental designs. Here we provide step-by-step instructions on how to perform kinetics experiments using biolayer interferometry. We further describe the basis and execution of competition and epitope binning experiments, which are particularly useful for antibody and nanobody screening applications. The procedure requires 3 h to complete and is suitable for users with minimal experience with biochemical techniques.

Indexed as

InterferometryProtein Interaction MappingProteinsSingle-Domain AntibodiesKineticsProtein BindingProteinsSingle-Domain Antibodies

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.